US Patent Issued to Exelixis on Dec. 23 for "Compounds for the treatment of kinase-dependent disorders" (California Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,438, issued on Dec. 23, was assigned to Exelixis Inc. (Alameda, Calif.).

"Compounds for the treatment of kinase-dependent disorders" was invented by Lynne Canne Bannen (Novato, Calif.), Minna Bui (Oakland, Calif.), Faming Jiang (Castro Valley, Calif.), Kin Tso (San Francisco), Yong Wang (South San Francisco, Calif.) and Wei Xu (Danville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds of Formula (I) which inhibit, regulate and/or modulate tyrosine kinase receptors, particularly Axl and Mer signal transduction pathways related to the changes in cellular activities, compositions containing the compounds, methods of...